drugset / Trial / NCT01250457

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

NCT01250457

Phase 4 Withdrawn Loyola University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to find out if the use of topical timolol 0.5% solution applied twice daily will help to shrink rosacea lesions around the eye.

Timeline

Start
2010-06
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Topical

Indications